SUPER DONOR Trademark

Trademark Overview


On Monday, July 15, 2019, a trademark application was filed for SUPER DONOR with the United States Patent and Trademark Office. The USPTO has given the SUPER DONOR trademark a serial number of 79268398. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 2, 2020. This trademark is owned by MYBIOTICS PHARMA LTD. The SUPER DONOR trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks in the nature of powdered and ready-to-drink beverages; dietary food supplements; dietary supplement drink mixes; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered food supplements; powdered nutritional supplements; probiotic supplements; probiotic dietary supplements; probiotic preparations for medical use; sedatives; antifungal medication in the nature of antifungal preparations; medicines for alleviating constipation; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of hormonal disorders; medicines for treating intestinal disorders; preparations for treating colds; burn relief medication; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical antitussive-cold preparations; nonprescription medicin...
super donor

General Information


Serial Number79268398
Word MarkSUPER DONOR
Filing DateMonday, July 15, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, December 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks in the nature of powdered and ready-to-drink beverages; dietary food supplements; dietary supplement drink mixes; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered food supplements; powdered nutritional supplements; probiotic supplements; probiotic dietary supplements; probiotic preparations for medical use; sedatives; antifungal medication in the nature of antifungal preparations; medicines for alleviating constipation; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of hormonal disorders; medicines for treating intestinal disorders; preparations for treating colds; burn relief medication; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical antitussive-cold preparations; nonprescription medicine, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders, non-medicated topical gel for the prevention and treatment of allergies, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria, for the prevention and treatment of bacterial vaginosis and related women health disorders, for supporting oncology treatments, antibiotic associated diarrhea; medicines for dental purposes; medicines for veterinary purposes, namely, antioxidants, veterinary preparations for treatment of intestinal bacteria; pain relief medication; decongestant capsules; herbal medicines being medicinal herbal preparations; antihypertensives; antitussives; diarrhea medication; antiflatulents; antiemetics; antivirals; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; medicines for treating gastrointestinal diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMYBIOTICS PHARMA LTD
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIL

Trademark Events


Event DateEvent Description
Sunday, December 19, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 2, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, December 2, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, March 20, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, December 2, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, December 2, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, June 26, 2020REFUSAL PROCESSED BY IB
Thursday, May 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 21, 2020NON-FINAL ACTION E-MAILED
Thursday, May 21, 2020NON-FINAL ACTION WRITTEN
Tuesday, April 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 16, 2019REFUSAL PROCESSED BY IB
Tuesday, October 29, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 29, 2019REFUSAL PROCESSED BY MPU
Wednesday, October 9, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 8, 2019NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2019APPLICATION FILING RECEIPT MAILED
Friday, October 4, 2019ASSIGNED TO EXAMINER
Friday, October 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 26, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB